{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Quincy Biosciences: What the decision means for advertising of health claims, and what it means to the FTC",
"url": "https://www.lexblog.com/2017/11/22/quincy-biosciences-advertising-health-claims/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-X4X72AAV",
"url": "https://www.lexblog.com/lib/X4X72AAV/"
},
"datePublished": "2017-11-22T10:56:55-05:00",
"dateModified": "2023-04-26T12:40:35-04:00",
"author": {
"@type": "Person",
"name": "Crowell & Moring, Christopher A. Cole"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Crowell & Moring LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Retail & Consumer Products Law Observer",
"about": "Business and Commercial",
"sourceUrl": "https://www.retailconsumerproductslaw.com/?p=2585",
"sourceStability": "may-move"
}